Magnetic resonance imaging of tumors colonized with bacterial ferritin-expressing Escherichia coli

PLoS ONE

Volumn 6, Issue 10, 2011, Pages

  Hill, Philip J ^a,b   Stritzker, Jochen ^a,d,e   Scadeng, Miriam ^g   Geissinger, Ulrike ^a   Haddad, Daniel ^f   Basse Lüsebrink, Thomas C ^f   Gbureck, Uwe ^c   Jakob, Peter ^f   Szalay, Aladar A ^a,c,d,e  

^a GENELUX CORPORATION   (United States)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^c UNIVERSITY OF WÜRZBURG   (Germany)

^d Institute of Biochemistry   (Germany)

^e UNIVERSITY OF WÜRZBURG   (Germany)

^f Institute for Experimental Physics V and MRB Research Center   (Germany)

^g UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIOFERRITIN; PROBIOTIC AGENT; BFR PROTEIN, E COLI; ESCHERICHIA COLI PROTEIN; IRON; METALLOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM CULTURE; CONTROLLED STUDY; ESCHERICHIA COLI; FLUORESCENCE MICROSCOPY; GENE EXPRESSION; IRON TRANSPORT; MOUSE; NISSL SUBSTANCE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REPORTER GENE; SITE DIRECTED MUTAGENESIS; TUMOR; ANIMAL; BACTERIAL COUNT; BAGG ALBINO MOUSE; FEMALE; GROWTH, DEVELOPMENT AND AGING; HUMAN; METABOLISM; MICROBIOLOGY; NEOPLASM;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; MUS;

ANIMALS; COLONY COUNT, MICROBIAL; ESCHERICHIA COLI; ESCHERICHIA COLI PROTEINS; FEMALE; HUMANS; IRON; MAGNETIC RESONANCE IMAGING; METALLOPROTEINS; MICE; MICE, INBRED BALB C; NEOPLASMS;

EID: 80053445448     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0025409     Document Type: Article

References (56)

1. Morrissey D, O'Sullivan GC, Tangney M, (2010) Tumour targeting with systemically administered bacteria. Curr Gene Ther 10: 3-14.
2. Van Mellaert L, Barbe S, Anne J, (2006) Clostridium spores as anti-tumour agents. Trends Microbiol 14: 190-196.
3. Vassaux G, Nitcheu J, Jezzard S, Lemoine NR, (2006) Bacterial gene therapy strategies. J Pathol 208: 290-298.
4. Ryan RM, Green J, Lewis CE, (2006) Use of bacteria in anti-cancer therapies. Bioessays 28: 84-94.
5. Taniguchi S, Fujimori M, Sasaki T, Tsutsui H, Shimatani Y, et al. (2010) Targeting solid tumors with non-pathogenic obligate anaerobic bacteria. Cancer Sci 101: 1925-1932.
6. Stritzker J, Weibel S, Hill PJ, Oelschlaeger TA, Goebel W, et al. (2007) Tumor-specific colonization, tissue distribution, and gene induction by probiotic Escherichia coli Nissle 1917 in live mice. Int J Med Microbiol.
7. Stritzker J, Hill PJ, Gentschev I, Szalay AA, (2010) Myristoylation negative msbB-mutants of probiotic E. coli Nissle 1917 retain tumor specific colonization properties but show less side effects in immunocompetent mice. Bioeng Bugs 1: 139-145.
8. Stritzker J, Weibel S, Seubert C, Gotz A, Tresch A, et al. (2010) Enterobacterial tumor colonization in mice depends on bacterial metabolism and macrophages but is independent of chemotaxis and motility. Int J Med Microbiol 300: 449-456.
9. Loessner H, Leschner S, Endmann A, Westphal K, Wolf K, et al. (2009) Drug-inducible remote control of gene expression by probiotic Escherichia coli Nissle 1917 in intestine, tumor and gall bladder of mice. Microbes Infect 11: 1097-1105.
10. Wall DM, Srikanth CV, McCormick BA, (2010) Targeting tumors with salmonella Typhimurium- potential for therapy. Oncotarget 1: 721-728.
11. Pawelek JM, Low KB, Bermudes D, (2003) Bacteria as tumour-targeting vectors. Lancet Oncol 4: 548-556.
12. Leschner S, Weiss S, (2010) Salmonella-allies in the fight against cancer. J Mol Med 88: 763-773.
13. Riedel CU, Monk IR, Casey PG, Morrissey D, O'Sullivan G C, et al. (2007) An improved luciferase tagging system for Listeria monocytogenes allows real-time monitoring in vivo and in vitro. Appl Environ Microbiol.
14. Yu YA, Shabahang S, Timiryasova TM, Zhang Q, Beltz R, et al. (2004) Visualization of tumors and metastases in live animals with bacteria and vaccinia virus encoding light-emitting proteins. Nat Biotechnol 22: 313-320.
15. Zhao M, Yang M, Ma H, Li X, Tan X, et al. (2006) Targeted therapy with a Salmonella typhimurium leucine-arginine auxotroph cures orthotopic human breast tumors in nude mice. Cancer Res 66: 7647-7652.
16. Soghomonyan SA, Doubrovin M, Pike J, Luo X, Ittensohn M, et al. (2005) Positron emission tomography (PET) imaging of tumor-localized Salmonella expressing HSV1-TK. Cancer Gene Ther 12: 101-108.
17. Bettegowda C, Foss CA, Cheong I, Wang Y, Diaz L, et al. (2005) Imaging bacterial infections with radiolabeled 1-(2′-deoxy-2′-fluoro-beta-D-arabinofuranosyl)-5-iodouracil. Proc Natl Acad Sci U S A 102: 1145-1150.
18. Brader P, Stritzker J, Riedl CC, Zanzonico P, Cai S, et al. (2008) Escherichia coli Nissle 1917 Facilitates Tumor Detection by Positron Emission Tomography and Optical Imaging. Clinical Can Res.
19. Harrison PM, Hempstead PD, Artymiuk PJ, Andrews SC, (1998) Structure-function relationships in the ferritins. Met Ions Biol Syst 35: 435-477.
20. Andrews SC, Arosio P, Bottke W, Briat JF, von Darl M, et al. (1992) Structure, function, and evolution of ferritins. J Inorg Biochem 47: 161-174.
21. Carrondo MA, (2003) Ferritins, iron uptake and storage from the bacterioferritin viewpoint. Embo J 22: 1959-1968.
22. Theil EC, (1987) Ferritin: structure, gene regulation, and cellular function in animals, plants, and microorganisms. Annu Rev Biochem 56: 289-315.
23. Cohen B, Dafni H, Meir G, Harmelin A, Neeman M, (2005) Ferritin as an endogenous MRI reporter for noninvasive imaging of gene expression in C6 glioma tumors. Neoplasia 7: 109-117.
24. Cohen B, Ziv K, Plaks V, Israely T, Kalchenko V, et al. (2007) MRI detection of transcriptional regulation of gene expression in transgenic mice. Nat Med 13: 498-503.
25. Deans AE, Wadghiri YZ, Bernas LM, Yu X, Rutt BK, et al. (2006) Cellular MRI contrast via coexpression of transferrin receptor and ferritin. Magn Reson Med 56: 51-59.
26. Genove G, DeMarco U, Xu H, Goins WF, Ahrens ET, (2005) A new transgene reporter for in vivo magnetic resonance imaging. Nat Med 11: 450-454.
27. Hasegawa S, Furukawa T, Saga T, (2010) Molecular MR imaging of cancer gene therapy: ferritin transgene reporter takes the stage. Magn Reson Med Sci 9: 37-47.
28. Ono K, Fuma K, Tabata K, Sawada M, (2009) Ferritin reporter used for gene expression imaging by magnetic resonance. Biochem Biophys Res Commun 388: 589-594.
29. Aung W, Hasegawa S, Koshikawa-Yano M, Obata T, Ikehira H, et al. (2009) Visualization of in vivo electroporation-mediated transgene expression in experimental tumors by optical and magnetic resonance imaging. Gene Ther 16: 830-839.
30. Liu J, Cheng EC, Long RC, Yang SH, Wang L, et al. (2009) Noninvasive monitoring of embryonic stem cells in vivo with MRI transgene reporter. Tissue Eng Part C Methods 15: 739-747.
31. Kim HS, Cho HR, Choi SH, Woo JS, Moon WK, (2010) In vivo imaging of tumor transduced with bimodal lentiviral vector encoding human ferritin and green fluorescent protein on a 1.5T clinical magnetic resonance scanner. Cancer Res 70: 7315-7324.
32. Brooks RA, Vymazal J, Goldfarb RB, Bulte JW, Aisen P, (1998) Relaxometry and magnetometry of ferritin. Magn Reson Med 40: 227-235.
33. Vymazal J, Zak O, Bulte JW, Aisen P, Brooks RA, (1996) T1 and T2 of ferritin solutions: effect of loading factor. Magn Reson Med 36: 61-65.
34. Gossuin Y, Muller RN, Gillis P, (2004) Relaxation induced by ferritin: a better understanding for an improved MRI iron quantification. NMR Biomed 17: 427-432.
35. Vymazal J, Brooks RA, Zak O, McRill C, Shen C, et al. (1992) T1 and T2 of ferritin at different field strengths: effect on MRI. Magn Reson Med 27: 368-374.
36. Lawson DM, Artymiuk PJ, Yewdall SJ, Smith JM, Livingstone JC, et al. (1991) Solving the structure of human H ferritin by genetically engineering intermolecular crystal contacts. Nature 349: 541-544.
37. Ford GC, Harrison PM, Rice DW, Smith JM, Treffry A, et al. (1984) Ferritin: design and formation of an iron-storage molecule. Philos Trans R Soc Lond B Biol Sci 304: 551-565.
38. Hempstead PD, Hudson AJ, Artymiuk PJ, Andrews SC, Banfield MJ, et al. (1994) Direct observation of the iron binding sites in a ferritin. FEBS Lett 350: 258-262.
39. Trikha J, Waldo GS, Lewandowski FA, Ha Y, Theil EC, et al. (1994) Crystallization and structural analysis of bullfrog red cell L-subunit ferritins. Proteins 18: 107-118.
40. Frolow F, Kalb AJ, Yariv J, (1994) Structure of a unique twofold symmetric haem-binding site. Nat Struct Biol 1: 453-460.
41. Lawson DM, Treffry A, Artymiuk PJ, Harrison PM, Yewdall SJ, et al. (1989) Identification of the ferroxidase centre in ferritin. FEBS Lett 254: 207-210.
42. Andrews SC, Findlay JB, Guest JR, Harrison PM, Keen JN, et al. (1991) Physical, chemical and immunological properties of the bacterioferritins of Escherichia coli, Pseudomonas aeruginosa and Azotobacter vinelandii. Biochim Biophys Acta 1078: 111-116.
43. Grossman MJ, Hinton SM, Minak-Bernero V, Slaughter C, Stiefel EI, (1992) Unification of the ferritin family of proteins. Proc Natl Acad Sci U S A 89: 2419-2423.
44. Andrews SC, Le Brun NE, Barynin V, Thomson AJ, Moore GR, et al. (1995) Site-directed replacement of the coaxial heme ligands of bacterioferritin generates heme-free variants. J Biol Chem 270: 23268-23274.
45. Grosse C, Scherer J, Koch D, Otto M, Taudte N, et al. (2006) A new ferrous iron-uptake transporter, EfeU (YcdN), from Escherichia coli. Mol Microbiol 62: 120-131.
46. Grozdanov L, Raasch C, Schulze J, Sonnenborn U, Gottschalk G, et al. (2004) Analysis of the genome structure of the nonpathogenic probiotic Escherichia coli strain Nissle 1917. J Bacteriol 186: 5432-5441.
47. Benoit MR, Mayer D, Barak Y, Chen IY, Hu W, et al. (2009) Visualizing implanted tumors in mice with magnetic resonance imaging using magnetotactic bacteria. Clin Cancer Res 15: 5170-5177.
48. Zurkiya O, Chan AW, Hu X, (2008) MagA is sufficient for producing magnetic nanoparticles in mammalian cells, making it an MRI reporter. Magn Reson Med 59: 1225-1231.
49. Hudson AJ, Andrews SC, Hawkins C, Williams JM, Izuhara M, et al. (1993) Overproduction, purification and characterization of the Escherichia coli ferritin. Eur J Biochem 218: 985-995.
50. Andrews SC, Robinson AK, Rodriguez-Quinones F, (2003) Bacterial iron homeostasis. FEMS Microbiol Rev 27: 215-237.
51. Weibel S, Stritzker J, Eck M, Goebel W, Szalay AA, (2008) Colonization of experimental murine breast tumours by Escherichia coli K-12 significantly alters the tumour microenvironment. Cell Microbiol 10: 1235-1248.
52. Westphal K, Leschner S, Jablonska J, Loessner H, Weiss S, (2008) Containment of tumor-colonizing bacteria by host neutrophils. Cancer Res 68: 2952-2960.
53. Buschiazzo PM, Terrell EB, Regen DM, (1970) Sugar transport across the blood-brain barrier. Am J Physiol 219: 1505-1513.
54. Eidelberg E, Fishman J, Hams ML, (1967) Penetration of sugars across the blood-brain barrier. J Physiol 191: 47-57.
55. Henderson PJ, Maiden MC, (1990) Homologous sugar transport proteins in Escherichia coli and their relatives in both prokaryotes and eukaryotes. Philos Trans R Soc Lond B Biol Sci 326: 391-410.
56. Foley JE, Cushman SW, Salans LB, (1978) Glucose transport in isolated rat adipocytes with measurements of L-arabinose uptake. Am J Physiol 234: E112-119.